Gene · 7292
Papers4,164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,164
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536671 | PubTator, text mining | PubMed |
| OX40L and IL-2 combination strategy for gastric cancer immunotherapy. | Transl Cancer Res | 2025 | 41510098 | PubTator, text mining | PubMed |
| The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy. | J Inflamm Res | 2025 | 41473600 | PubTator, text mining | PubMed |
| Acoustic immune reprogramming: a novel paradigm for spatiotemporally controlled immune regulation using ultrasound-responsive nanoplatforms. | Front Immunol | 2025 | 41472729 | PubTator, text mining | PubMed |
| OX40 Ligand Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Review of Phase II Clinical Trial Data. | Skin Therapy Lett | 2025 | 41370848 | PubTator, text mining | PubMed |
| Selective decoupling of IgG1 binding to viral Fc receptors restores antibody-mediated NK cell activation against HCMV. | Cell Rep | 2025 | 41343276 | PubTator, text mining | PubMed |
| Molecular subtyping and a seven-gene immune signature reveal heterogeneity in tumor microenvironment and prognosis of lung adenocarcinoma. | Eur J Med Res | 2025 | 41310864 | PubTator, text mining | PubMed |
| In vitro models to mimic tumor endothelial cell-mediated immune cell reprogramming in lung adenocarcinoma. | J Exp Clin Cancer Res | 2025 | 41310721 | PubTator, text mining | PubMed |
| Association Between FOXP3 and OX40 Expression in Adult T-Cell Leukemia Cells. | Viruses | 2025 | 41305468 | PubTator, text mining | PubMed |
| The OX40-OX40L Co-stimulatory pathway in dermatology: emerging frontiers for therapeutic approaches. | Inflamm Res | 2025 | 41266646 | PubTator, text mining | PubMed |
| [Single cell sequencing technology for analyzing the interaction between type 3 innate lymphoid cells and regulatory T cells in patients with fibrostenotic Crohn's disease]. | Zhonghua Yi Xue Za Zhi | 2025 | 41255010 | PubTator, text mining | PubMed |
| Regulatory T cell stability determines the efficiency of bile duct regeneration during cholangitis. | Cell Rep | 2025 | 41240338 | PubTator, text mining | PubMed |
| Constructing an immune-related prognostic model and exploring the function of HMGB3, TNFSF4, and CORO2A in breast cancer. | Transl Cancer Res | 2025 | 41234826 | PubTator, text mining | PubMed |
| [Connective tissue diseases: development predictors, multimorbidity variants, physical treatment methods. (Literature review)]. | Vopr Kurortol Fizioter Lech Fiz Kult | 2025 | 41217799 | PubTator, text mining | PubMed |
| Structural and evolutionary constraints shape adaptive landscapes of immune-related genes across mammalian phylogeny. | PLoS One | 2025 | 41202012 | PubTator, text mining | PubMed |
| Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics. | Front Immunol | 2025 | 41181158 | PubTator, text mining | PubMed |
| Implication of an exosome-based gene signature for estimating clinical outcomes of triple-negative breast cancer and assisting in individualized therapy. | Sci Rep | 2025 | 41162433 | PubTator, text mining | PubMed |
| Analysis of FNDC1 as a diagnostic marker and potential therapeutic target for ovarian serous cancer. | BMC Cancer | 2025 | 41102682 | PubTator, text mining | PubMed |
| Immune therapies for alopecia areata: evidence and new perspectives. | Expert Rev Clin Immunol | 2025 | 41082367 | PubTator, text mining | PubMed |
| Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy. | Front Immunol | 2025 | 41041320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7292/papers?page=6